A recent retrospective propensity matched study including 95 patients suffering from severe rhabdomyolysis with myoglobin levels > 10,000 ng/ml and undergoing CRRT with (n = 55) or without (n = 40) CytoSorb® therapy [49] found that kidney recovery occurred in a significantly higher proportion in the CytoSorb® treated group (31.4 vs. 11.4%, p = 0.04). Here, MB is linked to rhabdomyolysis.